First patient dosed in Ankyra's visceral tumour study of ANK-101 - Clinical Trials Arena

Retrieved on: 2024-11-07 00:25:03

Tags for this article:

Click the tags to see associated articles and topics

First patient dosed in Ankyra's visceral tumour study of ANK-101 - Clinical Trials Arena. View article details on hiswai:

Excerpt

Data Insights. The gold standard of business intelligence. Find out more. Part 1 of the trial, which focuses ...

Article found on: www.clinicaltrialsarena.com